Ann: WESTERN SYDNEY UNIVERSITY TO UNDERTAKE CLINICAL TRIALS, page-9

100%

I would like to see what was achieved for the $2 million we have already spent.

No guidance of what they expect to further spend in Australia.

If Australia was the right place to do the research, why did they not choose this from the beginning? They were located here. Many other companies already researching here. It seems to be an obvious choice?

Also very interesting to have a look at the current NICM clinical trials.

https://www.westernsydney.edu.au/nicm/research/clinical_trials